Pavlovian Conditioned Approach, Sign/goal-tracking, average of LatencyScore, ProbDiff, and ResponseBias on days 4 and 5 of testing
Tags: Behavior · Pavlovian conditioned approach · Conditioned reinforcement
Project: p50_paul_meyer_2014
2 loci · 2 genes with independent associations · 2 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr1 | 149199615 | 150594931 | 1 | 1 | 2.26e-07 | 1.49e-07 | 1.42e-01 | Tenm4 |
2 | chr1 | 152785136 | 154174144 | 1 | 1 | 1.29e-07 | 9.70e-07 | 5.99e-01 | Dgat2 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.29 |
Adipose | alternative TSS | 0 | 0 | 1.35 |
Adipose | gene expression | 0 | 0 | 1.28 |
Adipose | isoform ratio | 0 | 0 | 1.29 |
Adipose | intron excision ratio | 0 | 0 | 1.12 |
Adipose | mRNA stability | 0 | 0 | 1.31 |
BLA | alternative polyA | 0 | 0 | 1.34 |
BLA | alternative TSS | 0 | 0 | 1.29 |
BLA | gene expression | 0 | 0 | 1.3 |
BLA | isoform ratio | 0 | 0 | 1.33 |
BLA | intron excision ratio | 0 | 0 | 1.25 |
BLA | mRNA stability | 0 | 0 | 1.31 |
Brain | alternative polyA | 0 | 0 | 1.3 |
Brain | alternative TSS | 0 | 0 | 1.27 |
Brain | gene expression | 0 | 0 | 1.28 |
Brain | isoform ratio | 0 | 0 | 1.3 |
Brain | intron excision ratio | 0 | 0 | 1.24 |
Brain | mRNA stability | 0 | 0 | 1.27 |
Eye | alternative polyA | 0 | 0 | 1.43 |
Eye | alternative TSS | 0 | 0 | 1.27 |
Eye | gene expression | 0 | 0 | 1.37 |
Eye | isoform ratio | 0 | 0 | 1.25 |
Eye | intron excision ratio | 0 | 0 | 1.29 |
Eye | mRNA stability | 0 | 0 | 1.38 |
IL | alternative polyA | 0 | 0 | 1.25 |
IL | alternative TSS | 0 | 0 | 1.1 |
IL | gene expression | 0 | 0 | 1.3 |
IL | isoform ratio | 0 | 0 | 1.31 |
IL | intron excision ratio | 0 | 0 | 1.24 |
IL | mRNA stability | 0 | 0 | 1.29 |
LHb | alternative polyA | 0 | 0 | 1.36 |
LHb | alternative TSS | 0 | 0 | 1.43 |
LHb | gene expression | 0 | 0 | 1.27 |
LHb | isoform ratio | 0 | 0 | 1.3 |
LHb | intron excision ratio | 0 | 0 | 1.22 |
LHb | mRNA stability | 0 | 0 | 1.26 |
Liver | alternative polyA | 0 | 0 | 1.25 |
Liver | alternative TSS | 0 | 0 | 1.28 |
Liver | gene expression | 1 | 0 | 1.32 |
Liver | isoform ratio | 0 | 0 | 1.29 |
Liver | intron excision ratio | 0 | 0 | 1.3 |
Liver | mRNA stability | 0 | 0 | 1.32 |
NAcc | alternative polyA | 0 | 0 | 1.36 |
NAcc | alternative TSS | 0 | 0 | 1.26 |
NAcc | gene expression | 1 | 0 | 1.28 |
NAcc | isoform ratio | 0 | 0 | 1.3 |
NAcc | intron excision ratio | 0 | 0 | 1.22 |
NAcc | mRNA stability | 0 | 0 | 1.28 |
OFC | alternative polyA | 0 | 0 | 1.38 |
OFC | alternative TSS | 0 | 0 | 1.26 |
OFC | gene expression | 0 | 0 | 1.27 |
OFC | isoform ratio | 0 | 0 | 1.34 |
OFC | intron excision ratio | 0 | 0 | 1.23 |
OFC | mRNA stability | 0 | 0 | 1.29 |
PL | alternative polyA | 0 | 0 | 1.43 |
PL | alternative TSS | 0 | 0 | 1.33 |
PL | gene expression | 0 | 0 | 1.29 |
PL | isoform ratio | 0 | 0 | 1.28 |
PL | intron excision ratio | 0 | 0 | 1.23 |
PL | mRNA stability | 0 | 0 | 1.29 |
pVTA | alternative polyA | 0 | 0 | 1.37 |
pVTA | alternative TSS | 0 | 0 | 1.29 |
pVTA | gene expression | 0 | 0 | 1.3 |
pVTA | isoform ratio | 0 | 0 | 1.27 |
pVTA | intron excision ratio | 0 | 0 | 1.21 |
pVTA | mRNA stability | 0 | 0 | 1.29 |
RMTg | alternative polyA | 0 | 0 | 1.15 |
RMTg | alternative TSS | 0 | 0 | 1.14 |
RMTg | gene expression | 0 | 0 | 1.31 |
RMTg | isoform ratio | 0 | 0 | 1.11 |
RMTg | intron excision ratio | 0 | 0 | 1.23 |
RMTg | mRNA stability | 0 | 0 | 1.28 |